本页面由Tiger Trade Technology Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

70.84
-2.7500-3.74%
盘后:70.840.00000.00%19:30 EDT
成交量:33.18万
成交额:2,366.03万
市值:16.27亿
市盈率:15.60
高:73.59
开:73.59
低:70.44
收:73.59
52周最高:97.00
52周最低:69.58
股本:2,297.04万
流通股本:2,028.20万
量比:0.83
换手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
净资产收益率:20.46%
总资产收益率:5.45%
市净率:2.72
市盈率(LYR):21.34

数据加载中...

2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/30

重要事件披露

Form 8-K - Current report
2023/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

重要事件披露

Form 8-K - Current report
2023/08/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities